As Senior Manager Business Intelligence & Strategic Projects (m/f/d), you drive competitive intelligence, business analytics, forecasting, and market research activities to generate impactful, actionable insights for the global Biopharma organization.
In this highly visible role, you will shape strategic decision‑making across in‑line, pipeline, and business development programs while supporting global portfolio management processes.
This position can be based in Germany or Spain.
Your Responsibilities:
Business Intelligence, Forecasting & Reporting:
Oversee Competitive Intelligence, Business Intelligence and Business Analytics activities to ensure timely, high‑quality insights for global, regional, and local stakeholders
Provide relevant and actionable insights to BU Biopharma at all levels
Coach Business Intelligence Consultants
Lead performance monitoring of Fresenius Kabi and key competitors, including preparation and development of launch trackers and dashboards
Lead global market research projects defined by Global Marketing
Drive monthly and quarterly reporting activities across all relevant management and commercial stakeholders
Present findings, provide strategic recommendations, and implement approved actions
Portfolio Management & Strategy:
Support — and lead when required — the global portfolio management process, including Portfolio Review meetings, new product selection and lifecycle management assessments
Secondary Responsibilities:
Develop and monitor CI/BI/forecasting budgets
Coordinate activities with global, regional and country BI teams
Continuously enhance processes using digital tools and AI
Support global strategic priorities aligned with the overall biosimilar strategy
Your Qualifications:
Degree-level education, preferably in a scientific field; a postgraduate degree (MA, MS, MBA, PhD) is strongly preferred
Minimum of 5 years of experience in competitive intelligence and commercial analytics; portfolio management experience is a plus
Expertise in biosimilars market dynamics (US/EU focus) and strong understanding of product development and strategy
Proven ability in sales and cost forecasting as well as P&L reporting
Strong analytical skills, including excellent Excel‑based modelling capabilities
Ability to synthesize complex insights into clear, actionable recommendations for senior stakeholders
Strong collaboration skills and ability to influence without authority across multifunctional teams
Experience managing multiple projects and external vendors simultaneously; high attention to detail
Excellent communication and presentation skills; fluent English required; additional languages are an asset
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
